The abstract is read at the publisher; the summary is JClub's.
Bayesian analyses in trials require careful design, evaluation, and interpretation to ensure stakeholders and reviewers correctly understand the evidence produced.
- Why it matters: Misconceptions about how Bayesian trial results should be assessed can undermine rigorous evaluation and stakeholder confidence.
- What they did: The viewpoint outlines key considerations for designing, evaluating, and interpreting trials that use Bayesian analyses, aimed at reviewers and stakeholders.
- The result: It provides guidance that helps prevent misunderstanding of Bayesian trial findings and supports more rigorous review practices.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.